Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms

References

• Ebel B, Lemetais G, Beney L, et al. Impact of probiotics on risk factors for cardiovascular diseases. A review. Crit Rev Food Sci Nutr. 2014;54(2):175–189.
   PubMed Web of Science ®Google Scholar
• Wens I, Dalgas U, Stenager E, et al. Risk factors related to cardiovascular diseases and the metabolic syndrome in multiple sclerosis - a systematic review. Mult Scler. 2013;19(12):1556–1564.
   PubMed Web of Science ®Google Scholar
• Timmis A, Townsend N, Gale C, et al. European society of cardiology: cardiovascular disease statistics 2017. Eur Heart J. 2018;39(7):508–579.
   PubMed Web of Science ®Google Scholar
• Jensen HA, Mehta JL. Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis. Expert Rev Cardiovasc Ther. 2016;14(9):1021–1033.
   PubMed Web of Science ®Google Scholar
• Buttari B, Profumo E, Businaro R, et al. Oxidized haemoglobin-driven endothelial dysfunction and immune cell activation: novel therapeutic targets for atherosclerosis. Curr Med Chem. 2013;20(37):4806–4814.
   PubMed Web of Science ®Google Scholar
• Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103(5):398–406.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li HY, Li H, et al. Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells. J Cell Physiol. 2011;226(6):1694–1701.
   PubMed Web of Science ®Google Scholar
• Tillhon M, Guaman Ortiz LM, Lombardi P, et al. Berberine: new perspectives for old remedies. Biochem Pharmacol. 2012;84(10):1260–1267.
   PubMed Web of Science ®Google Scholar
• McCubrey JA, Abrams SL, Lertpiriyapong K, et al. Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals. Adv Biol Regul. 2018;67:190–211.
   PubMedGoogle Scholar
• Neag MA, Mocan A, Echeverria J, et al. Berberine: botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders. Front Pharmacol. 2018;9:557.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Watts GF. Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications? Curr Opin Lipidol. 2017;28(3):282–283.
   PubMed Web of Science ®Google Scholar
• Xue M, Zhang L, Yang MX, et al. Berberine-loaded solid lipid nanoparticles are concentrated in the liver and ameliorate hepatosteatosis in db/db mice. Int J Nanomedicine. 2015;10:5049–5057.
   PubMed Web of Science ®Google Scholar
• Feng X, Sureda A, Jafari S, et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923–1951.
   PubMed Web of Science ®Google Scholar
• Hsieh YS, Kuo WH, Lin TW, et al. Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells. J Agric Food Chem. 2007;55(25):10437–10445.
   PubMed Web of Science ®Google Scholar
• Guo J, Wang L, Wang L, et al. Berberine protects human umbilical vein endothelial cells against LPS-induced apoptosis by blocking JNK-mediated signaling. Evid Based Complement Alternat Med. 2016;2016:6983956.
   PubMed Web of Science ®Google Scholar
• Khandelwal VK, Mitrofan LM, Hyttinen JM, et al. Oxidative stress plays an important role in zoledronic acid-induced autophagy. Physiol Res. 2014;63(Suppl 4):S601–12.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Levine B. Autophagy in mammalian development and differentiation. Nat Cell Biol. 2010;12(9):823–830.
   PubMed Web of Science ®Google Scholar
• Shimomura H, Terasaki F, Hayashi T, et al. Autophagic degeneration as a possible mechanism of myocardial cell death in dilated cardiomyopathy. Jpn Circ J. 2001;65(11):965–968.
   PubMedGoogle Scholar
• Jiang C, Jiang L, Li Q, et al. Pyrroloquinoline quinine ameliorates doxorubicin-induced autophagy-dependent apoptosis via lysosomal-mitochondrial axis in vascular endothelial cells. Toxicology. 2019;425:152238.
   PubMed Web of Science ®Google Scholar
• Mohammadinejad R, Ahmadi Z, Tavakol S, et al. Berberine as a potential autophagy modulator. J Cell Physiol. 2019;234(9):14914–14926.
   PubMed Web of Science ®Google Scholar
• Chen H, Ji Y, Yan X, et al. Berberine attenuates apoptosis in rat retinal Muller cells stimulated with high glucose via enhancing autophagy and the AMPK/mTOR signaling. Biomed Pharmacother. 2018;108:1201–1207.
   PubMed Web of Science ®Google Scholar
• Jia Z, Lin L, Huang S, et al. Inhibition of autophagy by berberine enhances the survival of H9C2 myocytes following hypoxia. Mol Med Rep. 2017;16(2):1677–1684.
   PubMed Web of Science ®Google Scholar
• Tang H, Ge H, Chen ZB, et al. Micrometam C protects against oxidative stress in inflammation models in zebrafish and RAW264.7. Macrophages. Mar Drugs. 2015;13(9):5593–5605.
   PubMed Web of Science ®Google Scholar
• Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest. 2006;86(1):9–22.
   PubMed Web of Science ®Google Scholar
• Godo S, Shimokawa H. Endothelial functions. Arterioscler Thromb Vasc Biol. 2017;37(9):e108–e14.
   PubMed Web of Science ®Google Scholar
• Zhuang W, Qin Z, Liang Z. The role of autophagy in sensitizing malignant glioma cells to radiation therapy. Acta Biochim Biophys Sin (Shanghai). 2009;41(5):341–351.
   PubMed Web of Science ®Google Scholar
• Fan X, Wang J, Hou J, et al. Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. J Transl Med. 2015;13(1):92.
   PubMedGoogle Scholar
• Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol. 2008;445:77–88.
   PubMedGoogle Scholar
• Wang J, Liu Y, Li XH, et al. Curcumin protects neuronal cells against status-epilepticus-induced hippocampal damage through induction of autophagy and inhibition of necroptosis. Can J Physiol Pharmacol. 2017;95(5):501–509.
   PubMed Web of Science ®Google Scholar
• Xia F, Wang C, Jin Y, et al. Luteolin protects HUVECs from TNF-alpha-induced oxidative stress and inflammation via its effects on the Nox4/ROS-NF-kappaB and MAPK pathways. J Atheroscler Thromb. 2014;21(8):768–783.
   PubMed Web of Science ®Google Scholar
• Klein SR, Piya S, Lu Z, et al. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015;34(41):5295–5301.
   PubMed Web of Science ®Google Scholar